AUD 0.04
(-5.26%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 | 1.54 Million AUD | 179.5% |
2023 | 553.47 Thousand AUD | -17.81% |
2022 | 673.43 Thousand AUD | 148.47% |
2021 | 271.02 Thousand AUD | 290.89% |
2020 | 69.33 Thousand AUD | -43.58% |
2019 | 122.89 Thousand AUD | 0.0% |
2018 | - AUD | 0.0% |
2017 | - AUD | 0.0% |
2016 | - AUD | 0.0% |
2015 | - AUD | 0.0% |
2014 | - AUD | 0.0% |
2013 | - AUD | 0.0% |
2012 | - AUD | 0.0% |
2011 | - AUD | 0.0% |
2010 | - AUD | 0.0% |
2009 | - AUD | 0.0% |
2008 | - AUD | 0.0% |
2007 | - AUD | 0.0% |
2006 | - AUD | 0.0% |
2005 | - AUD | 0.0% |
2004 | - AUD | 0.0% |
2003 | - AUD | 0.0% |
2002 | - AUD | -100.0% |
2001 | 1.21 Million AUD | 326.48% |
2000 | 285 Thousand AUD | 18.26% |
1999 | 241 Thousand AUD | -60.1% |
1998 | 604 Thousand AUD | 7.09% |
1997 | 564 Thousand AUD | -18.61% |
1996 | 693 Thousand AUD | 10.88% |
1995 | 625 Thousand AUD | 1738.24% |
1994 | 34 Thousand AUD | -44.26% |
1993 | 61 Thousand AUD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 4.17 Million AUD | 0.0% |
2024 FY | 1.54 Million AUD | 179.5% |
2024 Q4 | 1.54 Million AUD | 0.0% |
2023 Q2 | 427.7 Thousand AUD | 0.0% |
2023 Q4 | 553.47 Thousand AUD | 0.0% |
2023 FY | 553.47 Thousand AUD | -17.81% |
2022 FY | 673.43 Thousand AUD | 148.47% |
2022 Q2 | - AUD | 0.0% |
2022 Q4 | 673.43 Thousand AUD | 0.0% |
2021 FY | 271.02 Thousand AUD | 290.89% |
2021 Q2 | - AUD | 0.0% |
2021 Q4 | 271.02 Thousand AUD | 0.0% |
2020 FY | 69.33 Thousand AUD | -43.58% |
2020 Q4 | 69.33 Thousand AUD | 0.0% |
2020 Q2 | 36.91 Thousand AUD | 0.0% |
2019 FY | 122.89 Thousand AUD | 0.0% |
2019 Q4 | 122.89 Thousand AUD | 0.0% |
2019 Q2 | 94.94 Thousand AUD | 0.0% |
2018 Q2 | - AUD | 0.0% |
2018 FY | - AUD | 0.0% |
2018 Q4 | - AUD | 0.0% |
2017 FY | - AUD | 0.0% |
2017 Q4 | - AUD | 0.0% |
2017 Q2 | - AUD | 0.0% |
2016 Q4 | - AUD | 0.0% |
2016 FY | - AUD | 0.0% |
2016 Q2 | - AUD | 0.0% |
2015 Q2 | - AUD | 0.0% |
2015 FY | - AUD | 0.0% |
2015 Q4 | - AUD | 0.0% |
2014 Q2 | - AUD | 0.0% |
2014 FY | - AUD | 0.0% |
2014 Q4 | - AUD | 0.0% |
2013 Q2 | - AUD | 0.0% |
2013 Q4 | - AUD | 0.0% |
2013 FY | - AUD | 0.0% |
2013 Q1 | - AUD | 0.0% |
2013 Q3 | - AUD | 0.0% |
2012 Q4 | - AUD | 0.0% |
2012 FY | - AUD | 0.0% |
2011 Q4 | - AUD | 0.0% |
2011 FY | - AUD | 0.0% |
2010 FY | - AUD | 0.0% |
2010 Q4 | - AUD | 0.0% |
2009 FY | - AUD | 0.0% |
2009 Q4 | - AUD | 0.0% |
2008 FY | - AUD | 0.0% |
2008 Q4 | - AUD | 0.0% |
2007 FY | - AUD | 0.0% |
2007 Q4 | - AUD | 0.0% |
2006 FY | - AUD | 0.0% |
2006 Q4 | - AUD | 0.0% |
2005 FY | - AUD | 0.0% |
2005 Q4 | - AUD | 0.0% |
2004 Q4 | - AUD | 0.0% |
2004 FY | - AUD | 0.0% |
2003 FY | - AUD | 0.0% |
2003 Q4 | - AUD | 0.0% |
2002 Q4 | - AUD | 0.0% |
2002 FY | - AUD | -100.0% |
2001 Q4 | 1.21 Million AUD | 0.0% |
2001 FY | 1.21 Million AUD | 326.48% |
2000 Q4 | 285.72 Thousand AUD | 0.0% |
2000 FY | 285 Thousand AUD | 18.26% |
1999 Q4 | 241 Thousand AUD | 0.0% |
1999 FY | 241 Thousand AUD | -60.1% |
1998 FY | 604 Thousand AUD | 7.09% |
1997 Q4 | 564 Thousand AUD | 0.0% |
1997 FY | 564 Thousand AUD | -18.61% |
1996 FY | 693 Thousand AUD | 10.88% |
1995 FY | 625 Thousand AUD | 1738.24% |
1994 FY | 34 Thousand AUD | -44.26% |
1993 FY | 61 Thousand AUD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
EZZ Life Science Holdings Limited | 123.85 Thousand AUD | -1148.972% |
Anatara Lifesciences Ltd | - AUD | -Infinity% |
Zelira Therapeutics Limited | 5.65 Million AUD | 72.638% |
Biome Australia Limited | 1.3 Million AUD | -18.473% |
Patrys Limited | - AUD | -Infinity% |
Orthocell Limited | 689.69 Thousand AUD | -124.292% |
Noxopharm Limited | - AUD | -Infinity% |
PYC Therapeutics Limited | 1.11 Million AUD | -39.013% |
Chimeric Therapeutics Limited | - AUD | -Infinity% |
Prescient Therapeutics Limited | 330.48 Thousand AUD | -368.076% |
Proteomics International Laboratories Limited | 316.39 Thousand AUD | -388.923% |
Cynata Therapeutics Limited | - AUD | -Infinity% |
CSL Limited | 18.24 Billion AUD | 99.992% |
Arovella Therapeutics Limited | - AUD | -Infinity% |
Bio-Gene Technology Limited | - AUD | -Infinity% |
Clinuvel Pharmaceuticals Limited | 879.78 Thousand AUD | -75.83% |
Starpharma Holdings Limited | 3.52 Million AUD | 56.153% |
Nanollose Limited | 42.53 Thousand AUD | -3537.261% |
Memphasys Limited | 4.41 Million AUD | 64.948% |
Invex Therapeutics Ltd | - AUD | -Infinity% |
NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
Amplia Therapeutics Limited | 1.56 Million AUD | 0.947% |
Botanix Pharmaceuticals Limited | - AUD | -Infinity% |
Island Pharmaceuticals Limited | 421.96 Thousand AUD | -266.598% |
Race Oncology Limited | - AUD | -Infinity% |
Nyrada Inc. | - AUD | -Infinity% |
Telix Pharmaceuticals Limited | 17.44 Million AUD | 91.133% |
Dimerix Limited | 149.68 Thousand AUD | -933.469% |
PharmAust Limited | - AUD | -Infinity% |
Immutep Limited | 1.22 Million AUD | -25.944% |
Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
Alterity Therapeutics Limited | 159.04 Thousand AUD | -872.635% |
BTC Health Limited | - AUD | -Infinity% |
Acrux Limited | 1.48 Million AUD | -4.03% |
Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
Biotron Limited | 7130.00 AUD | -21596.031% |
Tissue Repair Ltd | - AUD | -Infinity% |
AdAlta Limited | 2.49 Million AUD | 37.988% |
Radiopharm Theranostics Limited | - AUD | -Infinity% |
Hexima Limited | - AUD | -Infinity% |
AnteoTech Limited | 23.59 Thousand AUD | -6456.998% |
Paradigm Biopharmaceuticals Limited | 239.33 Thousand AUD | -546.357% |
Recce Pharmaceuticals Ltd | 811.19 Thousand AUD | -90.698% |
Avecho Biotechnology Limited | 175.15 Thousand AUD | -783.196% |
Actinogen Medical Limited | 319.06 Thousand AUD | -384.825% |
Immuron Limited | 173.49 Thousand AUD | -791.616% |
Argenica Therapeutics Limited | - AUD | -Infinity% |